These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 28414204

  • 1. Docking-based structural splicing and reassembly strategy to develop novel deazapurine derivatives as potent B-RafV600E inhibitors.
    Wang GM, Wang X, Zhu JM, Guo BB, Yang Z, Xu ZJ, Li B, Wang HY, Meng LH, Zhu WL, Ding J.
    Acta Pharmacol Sin; 2017 Jul; 38(7):1059-1068. PubMed ID: 28414204
    [Abstract] [Full Text] [Related]

  • 2. Imidazothiazole-based potent inhibitors of V600E-B-RAF kinase with promising anti-melanoma activity: biological and computational studies.
    Anbar HS, El-Gamal MI, Tarazi H, Lee BS, Jeon HR, Kwon D, Oh CH.
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1712-1726. PubMed ID: 32962435
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Design, synthesis, and biological evaluation of novel imidazole derivatives possessing terminal sulphonamides as potential BRAFV600Einhibitors.
    Ali EMH, Abdel-Maksoud MS, Ammar UM, Mersal KI, Ho Yoo K, Jooryeong P, Oh CH.
    Bioorg Chem; 2021 Jan; 106():104508. PubMed ID: 33280830
    [Abstract] [Full Text] [Related]

  • 5. Design and synthesis of novel 2,3-dihydropyrazino[1,2-a]indole-1,4-dione derivatives as antiproliferative EGFR and BRAFV600E dual inhibitors.
    Al-Wahaibi LH, Gouda AM, Abou-Ghadir OF, Salem OIA, Ali AT, Farghaly HS, Abdelrahman MH, Trembleau L, Abdu-Allah HHM, Youssif BGM.
    Bioorg Chem; 2020 Nov; 104():104260. PubMed ID: 32920363
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Design and synthesis of N-(4-aminopyridin-2-yl)amides as B-Raf(V600E) inhibitors.
    Li X, Shen J, Tan L, Zhang Z, Gao D, Luo J, Cheng H, Zhou X, Ma J, Ding K, Lu X.
    Bioorg Med Chem Lett; 2016 Jun 15; 26(12):2760-2763. PubMed ID: 27155899
    [Abstract] [Full Text] [Related]

  • 8. Design and synthesis of novel pyrrolo[2,3-b]pyridine derivatives targeting V600EBRAF.
    Abdel-Maksoud MS, Ali EMH, Ammar UM, Mersal KI, Yoo KH, Oh CH.
    Bioorg Med Chem; 2020 Jun 01; 28(11):115493. PubMed ID: 32340792
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Design, synthesis, biological evaluation, and docking studies of novel (imidazol-5-yl)pyrimidine-based derivatives as dual BRAFV600E/p38α inhibitors.
    Ali EMH, El-Telbany RFA, Abdel-Maksoud MS, Ammar UM, Mersal KI, Zaraei SO, El-Gamal MI, Choi SI, Lee KT, Kim HK, Lee KH, Oh CH.
    Eur J Med Chem; 2021 Apr 05; 215():113277. PubMed ID: 33601311
    [Abstract] [Full Text] [Related]

  • 11. Ursolic acid interaction with transcription factors BRAF, V600E, and V600K: a computational approach towards new potential melanoma treatments.
    Aguilera-Durán G, Hernández-Castro S, Loera-García BV, Rivera-Vargas A, Alvarez-Baltazar JM, Cuevas-Flores MDR, Romo-Mancillas A.
    J Mol Model; 2024 Oct 10; 30(11):373. PubMed ID: 39387972
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Design and discovery of thioether and nicotinamide containing sorafenib analogues as multikinase inhibitors targeting B-Raf, B-RafV600E and VEGFR-2.
    Sun S, He Z, Huang M, Wang N, He Z, Kong X, Yao J.
    Bioorg Med Chem; 2018 May 15; 26(9):2381-2391. PubMed ID: 29631788
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Design and synthesis of a new series of highly potent RAF kinase-inhibiting triarylpyrazole derivatives possessing antiproliferative activity against melanoma cells.
    Khan MA, El-Gamal MI, Tarazi H, Choi HS, Oh CH.
    Future Med Chem; 2016 Dec 15; 8(18):2197-2211. PubMed ID: 27845592
    [Abstract] [Full Text] [Related]

  • 20. Design and synthesis of new potent anticancer benzothiazole amides and ureas featuring pyridylamide moiety and possessing dual B-Raf(V600E) and C-Raf kinase inhibitory activities.
    El-Damasy AK, Lee JH, Seo SH, Cho NC, Pae AN, Keum G.
    Eur J Med Chem; 2016 Jun 10; 115():201-16. PubMed ID: 27017549
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.